Trastuzumab deruxtecan in previously treated HER2-positive metastatic breast cancer: Plain language summary of the DESTINY-Breast01 study

Future Oncology, Ahead of Print.

Source: Future Oncology - July 15, 2021 Category: Cancer & Oncology Authors: Shanu Modi Source Type: research